Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer
- PMID: 27427428
- PMCID: PMC6372135
- DOI: 10.1093/ije/dyw129
Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer
Abstract
Background: Adiposity traits have been associated with risk of many cancers in observational studies, but whether these associations are causal is unclear. Mendelian randomization (MR) uses genetic predictors of risk factors as instrumental variables to eliminate reverse causation and reduce confounding bias. We performed MR analyses to assess the possible causal relationship of birthweight, childhood and adult body mass index (BMI), and waist-hip ratio (WHR) on the risks of breast, ovarian, prostate, colorectal and lung cancers.
Methods: We tested the association between genetic risk scores and each trait using summary statistics from published genome-wide association studies (GWAS) and from 51 537 cancer cases and 61 600 controls in the Genetic Associations and Mechanisms in Oncology (GAME-ON) Consortium.
Results: We found an inverse association between the genetic score for childhood BMI and risk of breast cancer [odds ratio (OR) = 0.71 per standard deviation (s.d.) increase in childhood BMI; 95% confidence interval (CI): 0.60, 0.80; P = 6.5 × 10(-5)). We also found the genetic score for adult BMI to be inversely associated with breast cancer risk (OR = 0.66 per s.d. increase in BMI; 95% CI: 0.57, 0.77; P = 2.5 × 10(-7)), and positively associated with ovarian cancer (OR = 1.35; 95% CI: 1.05, 1.72; P = 0.017), lung cancer (OR = 1.27; 95% CI: 1.09, 1.49; P = 2.9 × 10(-3)) and colorectal cancer (OR = 1.39; 95% CI: 1.06, 1.82, P = 0.016). The inverse association between genetically predicted adult BMI and breast cancer risk remained even after adjusting for directional pleiotropy via MR-Egger regression.
Conclusions: Findings from this study provide additional understandings of the complex relationship between adiposity and cancer risks. Our results for breast and lung cancer are particularly interesting, given previous reports of effect heterogeneity by menopausal status and smoking status.
Keywords: Cancer risk; Mendelian randomization; body mass index; post-GWAS study; waist-to-hip ratio.
© The Author 2016; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372135/bin/dyw129f1p.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/6372135/bin/dyw129f2p.gif)
Comment in
-
Commentary: Two-sample Mendelian randomization: opportunities and challenges.Int J Epidemiol. 2016 Jun;45(3):908-15. doi: 10.1093/ije/dyw127. Epub 2016 Jul 17. Int J Epidemiol. 2016. PMID: 27427429 Free PMC article. No abstract available.
Similar articles
-
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study.BMC Med. 2020 Dec 17;18(1):396. doi: 10.1186/s12916-020-01855-9. BMC Med. 2020. PMID: 33327948 Free PMC article.
-
Reassessing the causal role of obesity in breast cancer susceptibility: a comprehensive multivariable Mendelian randomization investigating the distribution and timing of exposure.Int J Epidemiol. 2023 Feb 8;52(1):58-70. doi: 10.1093/ije/dyac143. Int J Epidemiol. 2023. PMID: 35848946 Free PMC article.
-
Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.BMJ. 2017 Oct 31;359:j4761. doi: 10.1136/bmj.j4761. BMJ. 2017. PMID: 29089348 Free PMC article.
-
Serum 25-Hydroxyvitamin D and Cancer Risk: A Systematic Review of Mendelian Randomization Studies.Nutrients. 2023 Jan 13;15(2):422. doi: 10.3390/nu15020422. Nutrients. 2023. PMID: 36678292 Free PMC article. Review.
-
Body mass index and meniscal tears: Evidence from meta-analysis of observational studies and Mendelian randomization.Obes Rev. 2024 Jul;25(7):e13749. doi: 10.1111/obr.13749. Epub 2024 Apr 14. Obes Rev. 2024. PMID: 38616612 Review.
Cited by
-
Genetic predisposition to childhood obesity does not influence the risk of developing skin cancer in adulthood.Sci Rep. 2024 Apr 3;14(1):7854. doi: 10.1038/s41598-024-58418-8. Sci Rep. 2024. PMID: 38570581 Free PMC article.
-
Artificially sweetened beverages consumption and risk of obesity-related cancers: a wide-angled Mendelian randomization study.Front Nutr. 2024 Mar 6;11:1347724. doi: 10.3389/fnut.2024.1347724. eCollection 2024. Front Nutr. 2024. PMID: 38524848 Free PMC article.
-
Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis.Int J Obes (Lond). 2024 May;48(5):709-716. doi: 10.1038/s41366-024-01479-6. Epub 2024 Jan 31. Int J Obes (Lond). 2024. PMID: 38297030 Free PMC article.
-
Metabolic syndrome and risk of colorectal cancer: A Mendelian randomization study.Heliyon. 2023 Dec 19;10(1):e23872. doi: 10.1016/j.heliyon.2023.e23872. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38223733 Free PMC article.
-
Overweight-years and cancer risk: A prospective study of the association and comparison of predictive performance with body mass index (Atherosclerosis Risk in Communities Study).Int J Cancer. 2024 May 1;154(9):1556-1568. doi: 10.1002/ijc.34821. Epub 2023 Dec 24. Int J Cancer. 2024. PMID: 38143298 Free PMC article.
References
-
- McCallum V, Schneider-Levinson W . Obesity: A Provocative Question and the Search for Answers . Bethesda, MD: : Division of Cancer Epidemiology & Genetics, National Cancer Institute; , 2015. .
-
- Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L . Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women . Int J Cancer 2003. ; 106:96102 . - PubMed
-
- Song X, Pukkala E, Dyba T, et al. . Body mass index and cancer incidence: the FINRISK study . Eur J Epidemiol 2014. ; 29:477 – 87 . - PubMed
Publication types
MeSH terms
Grants and funding
- 16563/CRUK_/Cancer Research UK/United Kingdom
- C1178/A3947/CRUK_/Cancer Research UK/United Kingdom
- K99 ES023504/ES/NIEHS NIH HHS/United States
- R21 ES025052/ES/NIEHS NIH HHS/United States
- C490/A8339/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148537/CA/NCI NIH HHS/United States
- C1287/A16563/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148112/CA/NCI NIH HHS/United States
- R00 ES023504/ES/NIEHS NIH HHS/United States
- U19 CA148107/CA/NCI NIH HHS/United States
- P30 CA023108/CA/NCI NIH HHS/United States
- 076113/WT_/Wellcome Trust/United Kingdom
- 085475/WT_/Wellcome Trust/United Kingdom
- U19 CA148065/CA/NCI NIH HHS/United States
- R01 CA114343/CA/NCI NIH HHS/United States
- U19 CA148127/CA/NCI NIH HHS/United States
- C150/A5660/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous